Case Study

How Wellthy Therapeutics achieved a 130% increase in Blood Glucose monitoring for Roche Diagnostics (Accu-Chek® Active)

The pharmaceutical organization was looking for an experienced digital health partner to increase adherence for..

Case Study

How Wellthy Therapeutics co-developed a standalone SaMD for a leading specialty pharma in 7 months?

The pharmaceutical organization was looking for a reliable digital health partner to co-develop and..

Case Study

How Wellthy Therapeutics enabled evidence based remote care for a Leading health insurance organization in India?

Chronic Diseases are projected to account for 53% of all deaths in India. Deaths from chronic disease patients..

Case Study

How Wellthy Therapeutics enabled Comorbid patients with Virtual care pathways during Covid-19?

Comorbid Patients were the ones with higher risk of Covid contraction and were more prone to complications.

Case Study

Digital Therapeutics rise to offer continuous patient support and deliver outcomes for patients during a health crisis

In a country like India, with wide linguistic diversity, the digital therapeutics programmes with local language..

Case Study

How Roche Accu-Chek users achieved reduced glucose variability with a personalised diabetes management solution

Wellthy’s Digital therapeutics offered a personalized diabetes management solution to patients with chronic..

Case Study

Guiding patients to achieve significant blood pressure reduction

Our Digital therapeutics solution acted as a combination therapeutic offering lifestyle management solutions..

Case Study

How DTx can help manage multimorbidities

Digital therapeutic solutions offer a continuity of care through remote patient monitoring that helps keep the risk..

Case Study

How multilingual digital therapeutics is better adopted by patients across India

Digital Therapeutics proved its importance during the unforeseen pandemic with providing relief to..

Case Study

How digital therapeutics platform helps pharma tap into patients across India

Digital patient access programmes can tap the rural markets in India and offer increased access, improved awareness and augmented adherence

Whitepaper

Zero to One of Pharma-DTx relationships: Road from Development to Commercialization

Since the last decade we have seen a huge uptake in Digital Therapeutics(DTx) and witnessed a huge surge in DTx- Pharma partnerships.

Clinical-Evidence

ADCES

Digital Therapeutics to ensure continuity of diabetes care in times of COVID-19

Clinical-Evidence

American Diabetes Association

Impact of Using a Digital Therapeutic and Blood Glucose Meter on Glycemic Control and Variability

Clinical-Evidence

American College of Cardiology

Effectiveness of Digital Therapeutics to Improve Blood Pressure Control among
Patients with Hypertension and Diabetes in India

Clinical-Evidence

Advanced Technologies & Treatments for Diabetes

Effectiveness of Using a Digital Therapeutic with a Blood Glucose Monitor in Improving Glycaemic Control among Patients with Diabetes in India

Clinical-Evidence

International Diabetes Federation

Improving Glycemic Control Among IndianPatients with Type 2 Diabetes Using Wellthy CARETM Digital Therapeutic

Clinical-Evidence

Journal of Medical Internet Research

Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data : Peer Reviewed Publication

DTx Asia Roundup

The first DTx Asia conference was held in Seoul, South Korea last week where experts engaged in dialogues surrounding the penetration..

Digital Therapeutics in PAH: Augmenting care journeys for patients with rare, complex chronic disease

PAH is a rare, progressive, and complex chronic disease where increased pressure..

A Discussion on the Evolution of the DTx Industry – From Solutions to Platforms; DTx 1.0 to DTx 2.0

Due to pharma’s vast size and their desire to ‘test and learn’ they often create..

Lung Cancer: Addressing Gaps in Care for this Serious Non-Chronic Medical Condition Through Digital Therapeutics

More than half the people die within the first year of being diagnosed with Lung Cancer.

Wellthy Extends Global Footprint, Appoints Veteran Commercial Leader

Wellthy Therapeutics, the leader in advancing access to digital care in all parts of the world, today announced the appointment of Theo Ahadome as Chief Business Officer.

How do different types of DTx fit into a Drug Discovery Lifecycle?

Understanding the different types of DTx Understanding Digital Therapeutics (DTx) is key to understanding both its current and potential roles in the drug discovery lifecycle.

The Impact of Digital Therapeutics on Patient Health

What element do you think most influences a patient’s health? Social circumstances? Genetics? Treatments? Environment? ..

The 6 Simple Steps to Building Great Pharma DTx Partnerships

Having partnered with numerous pharma companies around the world, we know a fair bit about building great DTx partnerships at Wellthy.

Pharma Leader, Karine Soulat joins Wellthy therapeutics as VP Marketing

Introducing Karine Soulat, VP Marketing at Wellthy Therapeutics Wellthy Therapeutics is delighted to announce the arrival of Karine Soulat,..

Pulmonary Hypertension: How Wellthy’s digital tools can improve quality of life

Established by the PHA Association, Pulmonary Hypertension Awareness Month is now in its 30th year and encourages those who are connected to the condition to help spread awareness.

Wellthy Therapeutics complies to IEC:62304 medical device standard to build and scale robust SaMD solutions

The IEC 62304 standard outlines the life cycle processes, activities, and tasks that are required for the safe design..

Diabetes: Connecting the Dots for Collaborative Diabetes Care

The theme for this year’s Diabetes Awareness Month is, ‘Access to Diabetes Care: If not now, when?’..

The next stage of Pharma-DTx partnerships: what still remains unsolved?

The digital health ecosystem has grown at a tremendous pace in the last decade; not only when it comes to..

How Digital Therapeutics can handhold Healthcare workers to achieve optimal insulin titration

Patients with diabetes may require insulin therapy at a certain point in their journey of living with diabetes.

How can a DTX intervention reduce hypoglycemic episodes in patients on Insulin?

Hypoglycemia episodes are common among patients with diabetes and can vary in severity. The spectrum of these episodes may include: not experiencing any symptoms at all, ..

How to treat Congestive Heart Failure with Virtual Outpatient care via a DTX?

There is no such thing as a minor cardiac incident. Whether it’s a case of an intermittent angina or anacute discovery of hypertrophic cardiomyopathy – life is never the same afterwards.

Wellthy Therapeutics, a Software as Medical Device (SaMD) company achieves Class 1 CE mark for its Wellthy CARE™ Platform

Wellthy therapeutics Pvt. Ltd, a Software as Medical Device (SaMD) company remains compliant to EU MDR 2017/745 regulatory requirements and achieves ..

How to Prevent, Manage or treat Congestive Heart Failure during Covid using a Digital Therapeutic?

Synopsis:Heart failure remains a common and chronic illness across the world. It is not fully curable, but effective treatment and lifestyle changes can lead to..

Why patient support programs are the need of the hour

Synopsis:Patient Support Programs are services designed for patients and/or patient caregivers to help manage a treatment process.

The importance of medical adherence

Synopsis:Medication adherence is defined by the World Health Organization as “the degree to which the person’s behavior corresponds with the agreed recommendations from a..”

Understanding heart failure and How its one of the leading causes of Hospital readmissions

Synopsis:Heart failure is a serious condition in which the heart does not pump blood around the body efficiently.

How can Digital Therapeutics move the needle for Pharmaceutical Industry? Learnings from DTx West 2021

In the last couple years Digital health has gained huge mindshare across the Healthcare industry.

Why does Digital Health play an important role in revolutionizing Healthcare for Women?

As we celebrate International Women’s Day, we need to bear in mind that the well being of the women in your household or social circle can not be..

How to model a Patient Support Program for Type 2 Diabetes?

Type 2 Diabetes is a chronic condition that requires constant monitoring, and stringent medical adherence. With the emergence of Patient Support Program (PSPs), the wide gap between the..

How to transform patient engagement with value based care using Digital Therapeutics (DTx)?

The traditional fee-for-service model of healthcare is an inherently defective one because it leads to a conflict of interest between different stakeholders as..

How an effective post-care strategy can reduce heart failure readmissions rates for patients?

One of the primary and most concerning health problems is declining heart conditions and what tops the list is Congestive Heart Failure.

Bridging the gap in care continuum with Medtech

There was never a better time in then now to focus on medical innovation and tech-based healthcare delivery. Patients today are very evolved and are focused on proactive care and continuum of care.

Can digital solutions really help medical adherence?

The non-adherence of medical solutions and provisions by patients such as drugs, treatments or therapies is a cause of enormous concern in the healthcare world.

Using digital technology to lower risks; the new age insurance

Emerging technologies and innovations in digital technology are beginning to transform the insurance landscape as they enable new ways to measure, control, ..

Digital health ecosystems to expand the boundaries of value creation for insurers

Digitization and automation driven by newer data based technologies are changing the traditional landscape of many industries.

A Potential Game Changer in Value Based Drug Purchasing agreements

Value based drug purchasing model, to be implemented in USA in 2022, between payers, states and drug manufacturers where a drug will have multiple price..

Accelerating a seamless integration of digital health into traditional health insurance with DTx-Insurance collaboration

Availability of real-time and reliable health data from digital health tools, resolve of governments to combat..

A responsive approach to manage chronic diseases during a pandemic

With the emergence of the COVID-19 pandemic that spread globally at an accelerated pace, healthcare resources at all levels were shifted away from..

Augment Patient Outcomes through Remote Health Coaching

Neha Robin, the Star Health Coach at Wellthy Therapeutics shares her experience of working closely with people with chronic diseases.

How digital therapeutics can improve outcomes across the cardiac continuum

As the world is still limping back after the sabotage done by the COVID-19, on September 29, World Heart Day was observed by the healthcare sector ..

The rise of Digital therapeutics

Traditional Patient Support Programmes, although well-intentioned, with their focus being on medication support and low-touch condition education, struggled to drive care plan compliance with..

Wellness apps offer promises, Digital Therapeutics provides results, it’s time for Insurers to chose

Chronic diseases have long been an insurer’s Achilles heel The prevalence of chronic diseases like diabetes and cardiovascular conditions is on the..

Role of Digital Therapeutics(DTx) in Reforming the Insurance Industry

The rising cost of chronic conditions due to an increase in ageing population and changing
lifestyle is creating monumental pressure on health and life insurers worldwide.

Adding a digital zing to chronic diseases!

Medications are best complemented with digital health applications. The benefits would be seen not just in patients and healthcare providers, but would extend to all other sectors like pharma,

Why a Digital First Patient Support Program can drive Patient adherence?

Digital PSPs can play integrators, generate evidence in real world settings, and accelerate the journey to better patient health. As when the patient wins, everyone wins.

How Digital Patient Support Programs tackle Side Effects and improve medication adherence

Robust Patient Support Programmes help Pharmaceutical Companies to deal with the intricacies of chronic disease management; an important aspect .

Covid 19- Our catalyst to digitization in healthcare

COVID 19 resulted in unprecedented momentum in all arenas of healthcare industry and across all stakeholders – HCP conversations, patient ..

Adapting to Digital Patient Support Programs – The need of the hour!

With technological interventions in today’s time, ease and efficiency have
been two of the most important aspects of our everyday life.

Why a Digital First Patient Engagement strategy is key to Medication Adherence ?

The reasons for poor adherence are multifactorial (patient, physician, disease and health-system related); hence the measures to improve adherence need to be multi-pronged as well!